← Back to headlines
Transgene and NEC Publish Phase 1 Results for Cancer Therapy TG4050
Researchers reported a 100% three-year disease-free survival rate with TG4050 and shared their phase 1 findings in Nature Communications.
2 Sept, 16:00 — 2 Sept, 16:00
Related Stories
Actor Tim Curry Dies at 80 From Coronary Artery Disease
40m ago
Greece Reports Sharp Rise in West Nile Virus Cases Amid Public Health Alerts
1h ago
WHO to Launch Ebola Vaccine Trials in DRC as Death Toll Surpasses 3,000
2h ago
Pentagon Mandates Immediate Testosterone Screening for Male Troops Over 30
3h ago